Here is my take on the interview: - Very professional

New Post Public Reply Private Reply Replies (2) Message Board
Babaji
960
Here is my take on the interview:

- Very professional rebuttal of the Citron paper. Kept it short and dismissed it.

- MM Trial: will have 87 patients vs. 75. Stopped last Wednesday June 24th. 2 weeks to finish dosing, July 8th. Hospitals have to enter their data, confirm it and sign off, then unblinding can occur. Perhaps by July 22nd? On schedule and larger number of patients bodes well..

- SC trial: currently have 120 patients enrolled!! Wow, this got accelerated. His comment on deaths was more a concern about the "sad" part of such tests where the placebo patients are more likely to be dying as they are not getting Leronlimab. If you truly believed in your medicine, this would be the view point of any compassionate person. As for unblinding in this trial, the protocol allows this to be done at the 50 patient threshold and then the stats would be computed based on these 50 patients. My read on his comment "if FDA allows..." was probably in reference to the desire to include more than 50 patients in the analysis since they are at 120 patients enrolled already. This could help Leronlimab for a better 'p' value but he is not sure they would accommodate that.

- DISTRIBUTION: As NP said, post approval, getting the distribution would be the next bottle neck. His words, "GAME CHANGER," if the distributor he is going to sign up gets done! His words " A VERY WELL KNOWN PHARMA..." along with a big smile. We will know latest by MONDAY, maybe sooner!!!!!

- TIMOTHY BROWN the mystery HIV cured patient due to a bone marrow transplant in the UK .... Dr, Jonas Sacha (as I understand), based on his animal testing, thinks ithe cure can be replicated using Leronlimab which mimics (?) the genetic mutation that results in the loss of CCR5 in certain subsets of HIV infected patients. These HIV patients, when they undergo a bone transplant due to cancer, can now be potentially "cured of HIV!" WOW!! 10-15% of HIV patients due to cancer or other illnesses need bone marrow transplants.

- They have 2 patients ready to undergo this bone marrow treatment with Leronlimab, and if successful, they will file for a BTD immediately!!! Sorry, but I am getting overwhelmed with the potential of this miracle monoclonal antibody.

SO I AM THRILLED WITH THE INFO WE RECEIVED FROM Dr. NP TODAY.






1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 181

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 102

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 400

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 91

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Kal Raman Joins Photon to Drive Strategic AI Innovation Forward

Updated Category News Views 357

Kal Raman Joins Photon as Strategic Advisor to CEO Photon, a leader in digital and AI solutions, is excited to announce that Kal Raman has been appointed as a Strategic Advisor to the CEO. His primary focus will be to work closely with the executive leadership team to build strong relationships with major cloud and technology platforms in the AI ecosystem. This strategic...

Continue Reading
Fiverr's Q3 2024: Growth Strategies and Financial Insights

Updated Category News Views 319

Fiverr Reports Strong Q3 2024 Results Fiverr International Ltd. (NYSE: FVRR) has delivered impressive financial results for the third quarter of 2024. This success demonstrates the company's commitment to enhancing its services and reaching growth targets even amidst a challenging economic environment. Fiverr's strategy focuses on increasing its take rate by offering...

Continue Reading
Upcoming Legal Action for Jasper Therapeutics Investors Explained

Updated Category News Views 234

Legal Investigation Updates for Jasper Investors As the legal landscape around Jasper Therapeutics, Inc. (NASDAQ: JSPR) evolves, important updates are emerging for investors affected by recent developments. Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating claims on behalf of shareholders who may have suffered losses due to the...

Continue Reading
Naf Naf Grill Unveils Flavor-Packed Spiced Meatballs Today

Updated Category News Views 91

Introducing Spiced Meatballs at Naf Naf Grill Naf Naf Grill has just launched an exciting new dish: Spiced Meatballs. These flavorful meatballs are crafted with care to showcase the vibrant essence of Middle Eastern cuisine, making them a perfect addition to enhance your dining experience this fall. Rich Middle Eastern Flavors Made from 100% beef, these Spiced Meatballs...

Continue Reading
Pulmatrix Shares Q1 2025 Financial Results and New Directions

Updated Category News Views 170

Overview of Pulmatrix's Recent Developments Pulmatrix, Inc. is a biopharmaceutical entity focused on developing innovative inhaled therapeutic products to treat migraine and respiratory diseases, utilizing its specialized iSPERSE™ technology. In a recent announcement, the company outlined its financial performance for the first quarter of 2025. Key Financial Outcomes...

Continue Reading